Table of Contents
ISRN Neurology
Volume 2011, Article ID 959483, 6 pages
http://dx.doi.org/10.5402/2011/959483
Clinical Study

Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale

1Department of Clinical Neurological Sciences, Stroke Unit, University of Rome “Tor Vergata”, Viale Oxford 81, 00133 Rome, Italy
2I.R.C.C.S. Santa Lucia Foundation, Via Ardeatina 306, 00179 Rome, Italy
3Dipartimento di Cardiologia, Policlinico Tor Vergata, Università Tor Vergata, Viale Oxford 81, 00133 Rome, Italy

Received 18 October 2011; Accepted 10 November 2011

Academic Editors: G. Boysen and C. Lang

Copyright © 2011 Silvia Di Legge et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. E. Thaler and J. L. Saver, “Cryptogenic stroke and patent foramen ovale,” Current Opinion in Cardiology, vol. 23, no. 6, pp. 537–544, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. L. Mas, C. Arquizan, C. Lamy et al., “Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both,” New England Journal of Medicine, vol. 345, no. 24, pp. 1740–1746, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. S. Homma, R. L. Sacco, M. R. Di Tullio, R. R. Sciacca, and J. P. Mohr, “Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke study,” Circulation, vol. 105, no. 22, pp. 2625–2631, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. R. L. Sacco, R. Adams, G. Albers et al., “Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke—Co-sponsored by the Council on Cardiovascular Radiology and Intervention. The American Academy of Neurology affirms the value of this guideline,” Circulation, vol. 113, no. 10, pp. e409–e449, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. F. Büscheck, H. Sievert, F. Kleber et al., “Patent foramen ovale using the premere device: the results of the CLOSEUP trial,” Journal of Interventional Cardiology, vol. 19, no. 4, pp. 328–333, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. J. Wöhrle, “Closure of patent foramen ovale after cryptogenic stroke,” The Lancet, vol. 368, no. 9533, pp. 350–352, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. A. A. Khattab, S. Windecker, P. Jüni et al., “Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design,” Trials, vol. 12, no. 56, 2011. View at Publisher · View at Google Scholar · View at PubMed
  8. A. J. Furlan, M. Reisman, J. Massaro et al., “Study design of the CLOSURE i trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale,” Stroke, vol. 41, no. 12, pp. 2872–2883, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. M. Yahia, A. Shaukat, J. F. Kirmani, and A. I. Qureshi, “Age is not a predictor of patent foramen ovale with right-to-left shunt in patients with cerebral ischemic events,” Echocardiography, vol. 21, no. 6, pp. 517–522, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. Homma, M. R. DiTullio, R. L. Sacco, R. R. Sciacca, and J. P. Mohr, “Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale,” Stroke, vol. 35, no. 9, pp. 2145–2149, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. Handke, A. Harloff, M. Olschewski, A. Hetzel, and A. Geibel, “Patent foramen ovale and cryptogenic stroke in older patients,” New England Journal of Medicine, vol. 357, no. 22, pp. 2262–2268, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. V. Gupta, D. Yesilbursa, W. Y. Huang et al., “Patent foramen ovale in a large population of ischemic stroke patients: diagnosis, age distribution, gender, and race,” Echocardiography, vol. 25, no. 2, pp. 217–227, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. K. Lovett, M. S. Dennis, P. A. Sandercock, J. Bamford, C. P. Warlow, and P. M. Rothwell, “Very early risk of stroke after a first transient ischemic attack,” Stroke, vol. 34, no. 8, pp. 138–140, 2003. View at Google Scholar · View at Scopus
  14. J. K. Lovett, A. J. Coull, and P. M. Rothwell, “Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies,” Neurology, vol. 62, no. 4, pp. 569–573, 2004. View at Google Scholar · View at Scopus
  15. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Google Scholar
  16. T. Wessels, C. Röttger, M. Jauss, M. Kaps, H. Traupe, and E. Stol, “Identification of embolic stroke patterns by diffusion-weighted MRI in clinically defined lacunar stroke syndromes,” Stroke, vol. 36, no. 4, pp. 757–761, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. Jauss, T. Wessels, S. Trittmacher, J. Allendörfer, and M. Kaps, “Embolic lesion pattern in stroke patients with patent foramen ovale compared with patients lacking an embolic source,” Stroke, vol. 37, no. 8, pp. 2159–2161, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. E. De Marchis, S. Di Legge, F. Sallustio, P. Stanzione, M. Borzi, and F. Romeo, “Cryptogenic cerebral ischemia: clinical usefulness of a flexible ultrasound diagnostic algorithm for detection of patent foramen ovale,” Journal of Cardiovascular Medicine, vol. 12, no. 8, pp. 530–537, 2011. View at Publisher · View at Google Scholar · View at PubMed
  19. M. Jauss and E. Zanette, “Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography,” Cerebrovascular Diseases, vol. 10, no. 6, pp. 490–496, 2000. View at Google Scholar · View at Scopus
  20. A. C. Pearson, D. Nagelhout, R. Castello, C. R. Gomez, and A. J. Labovitz, “Atrial septal aneurysm and stroke: a transesophageal echocardiographic study,” Journal of the American College of Cardiology, vol. 18, no. 5, pp. 1223–1229, 1991. View at Google Scholar · View at Scopus
  21. B. Schneider, T. Zienkiewicz, V. Jansen, T. Hofmann, H. Noltenius, and T. Meinertz, “Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings,” American Journal of Cardiology, vol. 77, no. 14, pp. 1202–1209, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. G. P. Anzola, P. Zavarize, E. Morandi, L. Rozzini, and G. Parrinello, “Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale,” European Journal of Neurology, vol. 10, no. 2, pp. 129–135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Bogousslavsky, S. Garazi, X. Jeanrenaud, N. Aebischer, and G. Van Melle, “Stroke recurrence in patients with patent foramen ovale: the Lausanne study,” Neurology, vol. 46, no. 5, pp. 1301–1305, 1996. View at Google Scholar
  24. M. A. Almekhlafi, S. B. Wilton, D. M. Rabi, W. A. Ghali, D. L. Lorenzetti, and M. D. Hill, “Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis,” Neurology, vol. 73, no. 2, pp. 89–97, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. A. Arauz, L. Murillo, and J. M. Márquez, “Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale,” International Journal of Stroke. In press. View at Publisher · View at Google Scholar · View at PubMed
  26. N. Bissessor, A. W. Wong, L. A. Hourigan et al., “Percutaneous patent foramen ovale closure: and Amplatzer devices,” Cardiovascular Revascularization Medicine, vol. 12, no. 3, pp. 164–169, 2011. View at Publisher · View at Google Scholar · View at PubMed
  27. J. Kefer, T. Sluysmans, C. Hermans et al., “Percutaneous transcatheter closure of interatrial septal defect in adults: procedural outcome and long-term results,” Catheterization and Cardiovascular Interventions. In press. View at Publisher · View at Google Scholar · View at PubMed
  28. M. Paciaroni, G. Agnelli, A. Bertolini et al., “Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study,” Cerebrovascular Diseases, vol. 31, no. 2, pp. 109–116, 2011. View at Publisher · View at Google Scholar · View at PubMed
  29. J. G. Luermans, W. Budts, J. M. Ten Berg, H. W. Plokker, M. J. Suttorp, and M. C. Post, “Comparison of outcome after patent foramen ovale closure in older versus younger patients,” EuroIntervention, vol. 7, no. 2, pp. 209–215, 2011. View at Publisher · View at Google Scholar · View at PubMed
  30. C. Lamy, C. Giannesini, M. Zuber et al., “Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study,” Stroke, vol. 33, no. 3, pp. 706–711, 2002. View at Publisher · View at Google Scholar
  31. M. R. Di Tullio, C. Russo, Z. Jin, R. L. Sacco, J. P. Mohr, and S. Homma, “Aortic arch plaques and risk of recurrent stroke and death,” Circulation, vol. 119, no. 17, pp. 2376–2382, 2009. View at Publisher · View at Google Scholar · View at PubMed
  32. M. M. Steiner, M. R. Di Tullio, T. Rundek et al., “Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke,” Stroke, vol. 29, no. 5, pp. 944–948, 1998. View at Google Scholar · View at Scopus
  33. S. Homma, M. R. Di Tullio, R. L. Sacco, D. Mihalatos, G. Li Mandri, and J. P. Mohr, “Characteristics of patent foramen ovale associated with cryptogenic stroke: a biplane transesophageal echocardiographic study,” Stroke, vol. 25, no. 3, pp. 582–586, 1994. View at Google Scholar · View at Scopus
  34. J. Serena, J. Marti-Fàbregas, E. Santamarina et al., “Recurrent stroke and massive right-to-left shunt: results from the prospective spanish multicenter (CODICIA) study,” Stroke, vol. 39, no. 12, pp. 3131–3136, 2008. View at Publisher · View at Google Scholar · View at PubMed
  35. O. Ozdemir, V. Beletsky, V. Hachinski, and J. D. Spence, “Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome,” Journal of the Neurological Sciences, vol. 268, no. 1-2, pp. 193–194, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. F. Sallustio, S. Di Legge, M. Diomedi, and P. Stanzione, “Effect of a single oral dose of sildenafil on right-to-left shunt,” Cerebrovascular Diseases, vol. 32, no. 3, pp. 296–297, 2011. View at Publisher · View at Google Scholar · View at PubMed
  37. C. Tanislav, M. Kaps, M. Jauss et al., “Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale,” BMC Neurology, no. 10, article 123, 2010. View at Publisher · View at Google Scholar · View at PubMed
  38. G. Devuyst and J. Bogousslavsky, “Patent foramen ovale: the never-ending story,” Current Treatment Options in Cardiovascular Medicine, vol. 7, no. 3, pp. 227–239, 2005. View at Google Scholar · View at Scopus